[CNTA] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[CNTA] Centessa Pharmaceuticals plc
Announcement Date
13-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -55.30%
YoY- 28.26%
Quarter Report
CNTA's Result
CNTA's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
Revenue 0 0 0 0 0 -
PBT -41,958 -41,474 -54,016 -40,155 -2,138 110.36%
Tax 608 -2,826 -141 -65 -22 -
NP -42,566 -38,648 -53,875 -40,155 -2,138 111.12%
Tax Rate - - - - - -
Total Cost 42,566 38,648 53,875 40,155 2,138 111.12%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
EPS -0.37 -0.40 -0.57 -0.45 -0.01 146.48%
EPS Diluted -0.37 -0.40 -0.57 -0.45 -0.01 146.48%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.